Is Smith & Nephew plc a good investment? Smith & Nephew plc (SNN) is currently trading at 32.15 USD. Market analysts have a consensus price target of 34.07 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 22.61. This valuation is generally in line with the broader market.
Earnings Schedule: Smith & Nephew plc is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 2.28.
For income investors, Smith & Nephew plc pays a dividend yield of 2.43%. With a payout ratio of 53%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.78 USD (2.43% yield).
Smith & Nephew plc is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 1.43.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.48 USD
|
| May 10, 2027 (estimated) | 0.4821 |
| ▸2026 |
0.78 USD
|
| Nov. 9, 2026 (estimated) | 0.3000 |
| May 27, 2026 | 0.4820 |
| ▸2025 |
0.76 USD
|
| Nov. 7, 2025 | 0.3000 |
| May 28, 2025 | 0.4620 |
| ▸2024 |
0.75 USD
|
| Nov. 8, 2024 | 0.2880 |
| May 22, 2024 | 0.4620 |
| ▸2023 |
0.75 USD
|
| Nov. 1, 2023 | 0.2880 |
| May 17, 2023 | 0.4620 |
| ▸2022 |
1.48 USD
|
| Oct. 26, 2022 | 0.2780 |
| Sept. 29, 2022 | 0.2880 |
| May 11, 2022 | 0.4520 |
| March 31, 2022 | 0.4620 |
| ▸2021 |
1.03 USD
|
| Oct. 27, 2021 | 0.2780 |
| Sept. 30, 2021 | 0.2880 |
| May 12, 2021 | 0.4620 |
| ▸2020 |
1.03 USD
|
| Oct. 28, 2020 | 0.2780 |
| Oct. 1, 2020 | 0.2880 |
| May 6, 2020 | 0.4620 |
| ▸2019 |
0.73 USD
|
| Oct. 30, 2019 | 0.2880 |
| May 8, 2019 | 0.4400 |
| ▸2018 |
0.73 USD
|
| Oct. 31, 2018 | 0.2800 |
| May 9, 2018 | 0.4540 |
| ▸2017 |
0.62 USD
|
| Nov. 1, 2017 | 0.2460 |
| May 10, 2017 | 0.3700 |
| ▸2016 |
0.63 USD
|
| Oct. 25, 2016 | 0.2460 |
| May 11, 2016 | 0.3800 |
| ▸2015 |
0.61 USD
|
| Oct. 27, 2015 | 0.2360 |
| May 6, 2015 | 0.3720 |
| ▸2014 |
1.96 USD
|
| Nov. 12, 2014 | 0.5500 |
| Oct. 22, 2014 | 0.2200 |
| May 7, 2014 | 0.8500 |
| April 17, 2014 | 0.3401 |
| ▸2013 |
1.86 USD
|
| Oct. 29, 2013 | 0.5200 |
| Oct. 9, 2013 | 0.2081 |
| May 8, 2013 | 0.8100 |
| April 17, 2013 | 0.3241 |
| ▸2012 |
1.45 USD
|
| Oct. 30, 2012 | 0.4950 |
| Oct. 10, 2012 | 0.1981 |
| May 9, 2012 | 0.5400 |
| April 18, 2012 | 0.2161 |
| ▸2011 |
1.15 USD
|
| Nov. 1, 2011 | 0.3300 |
| Oct. 12, 2011 | 0.1321 |
| May 19, 2011 | 0.4910 |
| April 29, 2011 | 0.1965 |
| ▸2010 |
1.05 USD
|
| Nov. 2, 2010 | 0.3000 |
| Oct. 13, 2010 | 0.1200 |
| May 12, 2010 | 0.4465 |
| April 21, 2010 | 0.1789 |
| ▸2009 |
0.95 USD
|
| Nov. 3, 2009 | 0.2730 |
| Oct. 14, 2009 | 0.1092 |
| May 8, 2009 | 0.4060 |
| April 15, 2009 | 0.1625 |
| ▸2008 |
0.86 USD
|
| Nov. 7, 2008 | 0.2480 |
| Oct. 15, 2008 | 0.0992 |
| May 9, 2008 | 0.3690 |
| April 16, 2008 | 0.1477 |
| ▸2007 |
0.79 USD
|
| Nov. 9, 2007 | 0.2255 |
| Oct. 17, 2007 | 0.0904 |
| May 21, 2007 | 0.3372 |
| April 18, 2007 | 0.1329 |
| ▸2006 |
0.71 USD
|
| Nov. 10, 2006 | 0.2050 |
| Oct. 18, 2006 | 0.0820 |
| May 12, 2006 | 0.3050 |
| April 19, 2006 | 0.1220 |
| ▸2005 |
0.67 USD
|
| Nov. 21, 2005 | 0.1825 |
| Oct. 19, 2005 | 0.0752 |
| May 23, 2005 | 0.2964 |
| April 20, 2005 | 0.1188 |
| ▸2004 |
0.63 USD
|
| Nov. 22, 2004 | 0.1750 |
| Oct. 20, 2004 | 0.0684 |
| May 24, 2004 | 0.2714 |
| April 21, 2004 | 0.1160 |
| ▸2003 |
1.00 USD
|
| Sept. 22, 2003 | 0.2943 |
| Aug. 13, 2003 | 0.0596 |
| May 27, 2003 | 0.5397 |
| April 17, 2003 | 0.1086 |
| ▸2002 |
0.94 USD
|
| Nov. 25, 2002 | 0.3154 |
| Oct. 16, 2002 | 0.0628 |
| May 28, 2002 | 0.4688 |
| April 17, 2002 | 0.0914 |
| ▸2001 |
0.87 USD
|
| Dec. 17, 2001 | 0.2763 |
| Nov. 7, 2001 | 0.0556 |
| May 29, 2001 | 0.4440 |
| April 18, 2001 | 0.0902 |
| ▸2000 |
1.03 USD
|
| Dec. 18, 2000 | 0.2705 |
| Nov. 8, 2000 | 0.0550 |
| May 4, 2000 | 0.1391 |
| May 4, 2000 | 0.5689 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Smith & Nephew plc | May 27, 2026 | Paid | 0.482 USD |
| Smith & Nephew plc | Nov 07, 2025 | Paid | 0.3 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 7, 2000 | 0.820000 |
| Dec. 16, 2003 | 2.000000 |
| Oct. 15, 2014 | 2.499000 |
Community Discussion